13 August 2021 - Twenty years ago, the mapping of the human genome promised new opportunities for genomic or genetic tests to predict, prevent and even treat disease, tailored to specific patient sub-populations. 

For example, tests for breast cancer, such as Oncotype Dx, can analyse disease risk, and guide screening and treatment modalities for patients.

Read Forbes article